Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2023

Jun 5, 2023

3535_rns_2023-06-05_1755274a-4834-4eb3-a48b-b96b082bcebc.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

AQUA BIO TECHNOLOGY ASA - NEW SHARE CAPITAL REGISTERED

AQUA BIO TECHNOLOGY ASA - NEW SHARE CAPITAL REGISTERED

5.6.2023 14:26:48 CEST | Aqua Bio Technology ASA | Total number of voting rights

and capital

Reference is made to the stock exchange announcement from Aqua Bio Technology

ASA ("ABT" or the "Company") on 30 May 2023 regarding the board of directors

resolution to issue consideration shares to Varming Holding AS.

The share capital increase pertaining to the issuance of the new shares has

today been registered with the Norwegian Registry of Business Enterprises (Nw.

Foretaksregisteret). ABT's s new share capital is NOK 52,228,02.5 divided into

20,891,561 shares, each with a nominal value of NOK 2.5.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

* * *

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skin care products has been, and will continue to be, an

important part of the Company's strategy going forward. ABT is listed on the

Euronext Expand market of the Oslo Stock Exchange.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2414/3347/Download%20announcement

%20as%20PDF.pdf